The small number of cases with FBP1 deficiency identified during the neonatal period in our cohort likely indicates that this genetic disorder has a phenotypic spectrum broader than originally thought, with most subjects not experiencing any metabolic crises before their presenting episode. This evidence concerns the gene FBP1 and hereditary disease.